“Development of Advanced Nasal Sprays”
- The development of advanced nasal sprays has seen significant innovations aimed at enhancing efficacy, user comfort, and broadening therapeutic applications
- Haleon introduced Otrivin Nasal Mist, utilizing microdroplet technology to deliver a gentle mist that evenly covers nasal passages, minimizing dripping and enhancing user comfort
- Addressing patient concerns over preservatives, manufacturers such as Aptar Pharma have developed preservative-free intranasal spray systems, incorporating filter membranes to prevent microbial contamination without the need for preservatives
- The FDA approved FluMist for at-home use, allowing individuals up to age 49 to self-administer the influenza vaccine, thereby increasing accessibility and convenience
- Researchers have developed nasal sprays such as SPL7013, demonstrating potent antiviral activity against SARS-CoV-2, offering potential protection against COVID-19
- Innovations include nasal sprays formulated with natural ingredients, such as Zingiber officinalis extract, providing green and natural treatment options for rhinitis and rhinosinusitis
